Navigation Links
Insmed Announces First Quarter 2008 Financial Results
Date:5/8/2008

ll be available for seven days beginning today at 10:30 AM ET at 888-286-8010 (U.S. callers) or 617-801-6888 (international callers), using passcode 13315852.

About Insmed

Insmed Inc. is a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs. For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of product candidates, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our entrance into the follow on biologics market may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2007. Readers are cautioned not to place undue reliance on any forward-looking statements which
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...IK Surgery and vision correction experts listed in...y involved at the recently concluded American Acad...San Francisco, California. Dr. Stephen Brint, MD, ...rf, MD, Dr. Peter Rapoza, MD, Dr. Michael Raizman,...MD, Dr. Edward Manche, MD, and Dr. Parag Majmudar,...
(Date:11/4/2009)...s webinar, which will be presented on November 19 ... flow chemistry processing, will deal with the app...ious meso and micro scale flow chemistry equipment...as been recognized with several prestigious prizes...ahedron Prize. , Columbia...
(Date:11/4/2009)...4 DIATHERIX Laboratories, Inc. (DI...at the Michigan Security Network Homeland Security...ennis Grimaud, Chairman and Chief Executive Office...y,s advanced molecular diagnostic testing on bio-p... diagnosis and military efforts. ,, "This conf...
(Date:11/4/2009)...., Nov. 4 Zyngenia, Inc., a privat...eneration antibody drug development, today announc...ding from New Enterprise Associates (NEA), one of ...ital will be used to create novel, multi-specific ...iological targets with a single agent. The company...
Breaking Biology Technology:Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3DIATHERIX Laboratories Presents at Homeland Security Conference 2Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4
... is the World,s First Fully-Automated Random Acces...ay at AACC Meeting, SUNNYVALE, Calif., July 29 C...rt(R) Infinity-48 high-throughput system,at the 20...ual Meeting in,Washington, D.C. The newest additio...ostic testing systems delivers the world,s first a...
...LEY, Mass., July 29 Xceed,Molecular, a pioneer in...ne-expression analysis systems, will launch its ne... for use with the company,s Ziplex automated,gene-... Clinical Lab Expo,(booth 2155). The Clinical Lab ...n Center in Washington, DC., "With our expanding ...
...ate and local officials have taken steps to begin ...rials, a major step for a cutting-edge technology ...ment. , On July 28, the Cambridge (Mass.) Public... that Cambridge take several steps to gain a bette...chnology-related activities now underway within th...
Other Biology Technology:Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 2Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 3Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting 4Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155 2Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155 3Local officials move toward monitoring nanotechnologies 2Local officials move toward monitoring nanotechnologies 3
(Date:11/4/2009)... , St. Louis, MO, November 4, 2009 Childhood obe...portions. With more than one fourth of advertising...oods and beverages and continuing questions about ...he November/December issue of the Journal of Nutr...vertising aimed at children might be a large contr...
(Date:11/4/2009)... , MADISON, N.J., Oct. 20 /PRNewswire-FirstCa...), the world,s leading provider of diagnostic test...the third quarter ended September 30, 2009, income...or $1.02 per diluted share, from $160 million, or ...2008. In 2008, third quarter results were reduced ...
(Date:11/4/2009)... , WALL, N.J., Oct. 26 /PRNewswire-FirstCall/...d: BKYI), a leader in finger-based biometric ident... identity solutions at the AABB TXPO conference be... October 25-27 2009. BIO-key will provide hands-on...entification technology in booth #424. Also, at 5 ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17BIO-key(R) International Exhibiting at AABB TXPO 2Allied World U S Announces Strategic Response 28SM 29 Complimentary Service Added to General Liability Lead Umbrella Product 48376 1Allied World U S Announces Strategic Response 28SM 29 Complimentary Service Added to General Liability Lead Umbrella Product 48376 2Allied World U S Announces Strategic Response 28SM 29 Complimentary Service Added to General Liability Lead Umbrella Product 48376 3Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 1Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 2The secret of a snakes slither 8777 1
... Pretreatment with double-dose anticlotting medica...n (PCI) cuts the combined risk of heart attack and...ted at the 30th Annual Scientific Sessions of the ...ntions (SCAI), May 9?2, 2007, in Orlando, FL. , R... mg of clopidogrel before stenting, rather than th...
... Pigs carry hepatitis E virus (HEV), which they ca...ublished in Online Open Access journal BMC Veterin...o minimise the risk of human infection. The scenar...nfection rate in pigs drops. At low infection rate...s on HEV to humans at slaughter. , Kunio Satou and...
... Researchers at the University of Illinois at Chic...earch how an enzyme acts on the heart,s pacemaker ...-flight" reaction to adrenaline. , A single cell ...ing the pace of the beating heart, triggering its ...ll -- the pacemaker cell -- beats faster or slower...
Other Biology News:High-dose anticlotting drug cuts heart attack, death risk in half 2Slowing the racing heart 2
... ProteinPilot Software enables you to identify ove...u can distinguish protein isoforms, protein subset...alize peptide-protein associations and relationshi...ification and relative protein expression analysis...
... Motic's B3 series of microscopes offer all of the...laboratory work. Equipped with Koehler illuminatio...trast (ASC) objectives. The B3 is the workhorse of...cular tube eliminates the need for re-focusing fol...
SYBR Green II RNA gel stain*10,000X concentrate in DMSO**special packaging* from Molecular Probes (Invitrogen)
SYBR Green II RNA gel stain*10,000X concentrate in DMSO* from Molecular Probes (Invitrogen)
Biology Products: